Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 6385

1.

HIV Progression Depends on Codon and Amino Acid Usage Profile of Envelope Protein and Associated Host-Genetic Influence.

Roy A, Banerjee R, Basak S.

Front Microbiol. 2017 Jun 15;8:1083. doi: 10.3389/fmicb.2017.01083. eCollection 2017.

2.

Idiopathic esophageal ulcer as an initial manifestation of HIV infection.

Martín-Lagos Maldonado A, Guilarte López-Mañas J, Benavente Fernández A.

Rev Esp Enferm Dig. 2017 Aug;109(8):596-597. doi: 10.17235/reed.2017.5135/2017.

3.

The interaction between HIV-1 Nef and adaptor protein-2 reduces Nef-mediated CD4<sup>+</sup> T cell apoptosis.

Jacob RA, Johnson AL, Pawlak EN, Dirk BS, Van Nynatten LR, Haeryfar SMM, Dikeakos JD.

Virology. 2017 Sep;509:1-10. doi: 10.1016/j.virol.2017.05.018. Epub 2017 Jun 1.

PMID:
28577469
4.

Mortality in patients with HIV-1 and tuberculosis co-infection in Rio de Janeiro, Brazil - associated factors and causes of death.

da Silva Escada RO, Velasque L, Ribeiro SR, Cardoso SW, Marins LMS, Grinsztejn E, da Silva Lourenço MC, Grinsztejn B, Veloso VG.

BMC Infect Dis. 2017 May 30;17(1):373. doi: 10.1186/s12879-017-2473-y.

5.

Resveratrol-decreased hyperalgesia mediated by the P2X7 receptor in gp120-treated rats.

Wu B, Ma Y, Yi Z, Liu S, Rao S, Zou L, Wang S, Xue Y, Jia T, Zhao S, Shi L, Li L, Yuan H, Liang S.

Mol Pain. 2017 Jan-Dec;13:1744806917707667. doi: 10.1177/1744806917707667.

6.

Virological Control by the CD4-Binding Site Antibody N6 in Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys.

Julg B, Pegu A, Abbink P, Liu J, Brinkman A, Molloy K, Mojta S, Chandrashekar A, Callow K, Wang K, Chen X, Schmidt SD, Huang J, Koup RA, Seaman MS, Keele BF, Mascola JR, Connors M, Barouch DH.

J Virol. 2017 Jul 27;91(16). pii: e00498-17. doi: 10.1128/JVI.00498-17. Print 2017 Aug 15.

PMID:
28539448
7.

The impact of dark chocolate intake on arterial elasticity in individuals with HIV/AIDS undergoing ART: a randomized, double-blind, crossover trial.

Teixeira AMNDC, Luzia LA, de Souza SJ, de Almeida Petrilli A, Pontilho PM, de Souza JMP, Segurado AAC, Efraim P, Picone CM, Rondo PHC.

Food Funct. 2017 Jun 21;8(6):2212-2219. doi: 10.1039/c6fo01681b.

PMID:
28513635
8.

Autologous Stem Cell Transplantation Disrupts Adaptive Immune Responses during Rebound Simian/Human Immunodeficiency Virus Viremia.

Reeves DB, Peterson CW, Kiem HP, Schiffer JT.

J Virol. 2017 Jun 9;91(13). pii: e00095-17. doi: 10.1128/JVI.00095-17. Print 2017 Jul 1.

PMID:
28404854
9.

A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent <i>In Vitro</i>, <i>Ex Vivo</i>, and <i>In Vivo</i> Antiviral Activity.

Chong H, Xue J, Xiong S, Cong Z, Ding X, Zhu Y, Liu Z, Chen T, Feng Y, He L, Guo Y, Wei Q, Zhou Y, Qin C, He Y.

J Virol. 2017 May 12;91(11). pii: e00288-17. doi: 10.1128/JVI.00288-17. Print 2017 Jun 1.

PMID:
28356533
10.

Distinct transcriptome profiles of Gag-specific CD8+ T cells temporally correlated with the protection elicited by SIVΔnef live attenuated vaccine.

Lu W, Wan Y, Ma F, Johnson RP, Li Q.

PLoS One. 2017 Mar 23;12(3):e0173929. doi: 10.1371/journal.pone.0173929. eCollection 2017.

11.

[Effectiveness of prevention of mother to child HIV transmission in Henan province, 2002-2013].

Wang Q, Sun DY, Fan PY, Ma YM, Ma N, Si H, Li N, Wang Z.

Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Mar 10;38(3):359-363. doi: 10.3760/cma.j.issn.0254-6450.2017.03.017. Chinese.

PMID:
28329940
12.

Early antibody therapy can induce long-lasting immunity to SHIV.

Nishimura Y, Gautam R, Chun TW, Sadjadpour R, Foulds KE, Shingai M, Klein F, Gazumyan A, Golijanin J, Donaldson M, Donau OK, Plishka RJ, Buckler-White A, Seaman MS, Lifson JD, Koup RA, Fauci AS, Nussenzweig MC, Martin MA.

Nature. 2017 Mar 23;543(7646):559-563. doi: 10.1038/nature21435. Epub 2017 Mar 13.

13.

Antigenic and immunosuppressive properties of a trimeric recombinant transmembrane envelope protein gp41 of HIV-1.

Mühle M, Lehmann M, Hoffmann K, Stern D, Kroniger T, Luttmann W, Denner J.

PLoS One. 2017 Mar 10;12(3):e0173454. doi: 10.1371/journal.pone.0173454. eCollection 2017.

14.

Low implementation of Xpert MTB/RIF among HIV/TB co-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) program.

Clouse K, Blevins M, Lindegren ML, Yotebieng M, Nguyen DT, Omondi A, Michael D, Zannou DM, Carriquiry G, Pettit A; International Epidemiologic Databases to Evaluate AIDS (IeDEA) collaboration.

PLoS One. 2017 Feb 9;12(2):e0171384. doi: 10.1371/journal.pone.0171384. eCollection 2017.

15.

Changes in Circulating B Cell Subsets Associated with Aging and Acute SIV Infection in Rhesus Macaques.

Chang WL, Gonzalez DF, Kieu HT, Castillo LD, Messaoudi I, Shen X, Tomaras GD, Shacklett BL, Barry PA, Sparger EE.

PLoS One. 2017 Jan 17;12(1):e0170154. doi: 10.1371/journal.pone.0170154. eCollection 2017.

16.

No Evidence for Association of β-Defensin Genomic Copy Number with HIV Susceptibility, HIV Load during Clinical Latency, or Progression to AIDS.

Abujaber R, Shea PR, McLaren PJ, Lakhi S, Gilmour J, Allen S, Fellay J, Hollox EJ; IAVI Africa HIV Prevention Partnership, Swiss HIV Cohort Study.

Ann Hum Genet. 2017 Jan;81(1):27-34. doi: 10.1111/ahg.12182.

PMID:
28084001
17.

Phyloepidemiological Analysis Reveals that Viral Divergence Led to the Paucity of Simian Immunodeficiency Virus SIVmus/gsn/mon Infections in Wild Populations.

Schmidt F, Liegeois F, Greenwood EJ, LeBreton M, Lester J, Deleplancque L, Peeters M, Aghokeng A, Tamoufe U, Diffo JL, Takuo JM, Wolfe ND, Leroy E, Rouet F, Heeney JL.

J Virol. 2017 Feb 28;91(6). pii: e01884-16. doi: 10.1128/JVI.01884-16. Print 2017 Mar 15.

18.

Therapy of HIV Infection: Current Approaches and Prospects.

Prokofjeva MM, Kochetkov SN, Prassolov VS.

Acta Naturae. 2016 Oct-Dec;8(4):23-32.

19.

Characterization of founder viruses in very early SIV rectal transmission.

Yuan Z, Ma F, Demers AJ, Wang D, Xu J, Lewis MG, Li Q.

Virology. 2017 Feb;502:97-105. doi: 10.1016/j.virol.2016.12.018. Epub 2016 Dec 25.

PMID:
28027479
20.

An Evaluation of Selected Populations for HIV-1 Vaccine Cohort Development in Nigeria.

Njoku OS, Manak MM, O'Connell RJ, Shutt AL, Malia JA, Heipertz RA Jr, Tovanabutra S, Milazzo MJ, Akintunde GA, Alabi AS, Suleiman A, Ogundeji AA, Kene TS, Nelson R, Ayemoba OR, Singer DE, Robb ML, Peel SA, Michael NL.

PLoS One. 2016 Dec 9;11(12):e0166711. doi: 10.1371/journal.pone.0166711. eCollection 2016.

Supplemental Content

Loading ...
Support Center